121 related articles for article (PubMed ID: 699960)
1. The effect of gamma-acetylenic GABA, an enzyme-activated irreversible inhibitor of GABA-transaminase, on dopamine pathways of the extrapyramidal and limbic systems.
Palfreyman MG; Huot S; Lippert B; Schechter PJ
Eur J Pharmacol; 1978 Aug; 50(4):325-36. PubMed ID: 699960
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of dopaminergic activity in the extrapyramidal and limbic systems by gamma-acetylenic GABA [proceedings].
Huot S; Lippert B; Palfreyman MG; Schechter PJ
Br J Pharmacol; 1977 Jun; 60(2):264P-265P. PubMed ID: 880435
[No Abstract] [Full Text] [Related]
3. Dopamine agonist action in mesolimbic, cortical and extrapyramidal areas to modify spontaneous climbing behaviour of the mouse.
Costall B; Eniojukan JF; Naylor RJ
Psychopharmacology (Berl); 1985; 86(4):452-7. PubMed ID: 3929317
[TBL] [Abstract][Full Text] [Related]
4. gamma-Acetylenic GABA in tardive dyskinesia.
Casey DE; Gerlach J; Magelund G; Christensen TR
Arch Gen Psychiatry; 1980 Dec; 37(12):1376-9. PubMed ID: 6108751
[TBL] [Abstract][Full Text] [Related]
5. [Effect of an irreversible inhibitor (RMI71645) of gamma-aminobutyric acid (GABA) transaminase on spontaneous and conditioned activities of mice].
Misslin R; Hinschberger A; Ropartz P; Mandel P
C R Acad Hebd Seances Acad Sci D; 1976 Oct; 283(10):1221-4. PubMed ID: 827360
[TBL] [Abstract][Full Text] [Related]
6. Effects of gamma-vinyl GABA on food intake of rats.
Huot S; Palfreyman MG
Pharmacol Biochem Behav; 1982 Jul; 17(1):99-106. PubMed ID: 7122673
[TBL] [Abstract][Full Text] [Related]
7. Preferential effect of noncataleptogenic neuroleptics on mesolimbic dopaminergic function.
Bartholini G
Adv Biochem Psychopharmacol; 1977; 16():607-11. PubMed ID: 18902
[No Abstract] [Full Text] [Related]
8. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
Costall B; Marsden CD; Naylor RJ; Pycock CJ
Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
[TBL] [Abstract][Full Text] [Related]
9. Iron concentration reduced in ventral pallidum, globus pallidus, and substantia nigra by GABA-transaminase inhibitor, gamma-vinyl GABA.
Hill JM
Brain Res; 1985 Sep; 342(1):18-25. PubMed ID: 4041811
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of neuroleptic drugs on dopamine turnover in the extrapyramidal and limbic system.
Bartholini G
J Pharm Pharmacol; 1976 May; 28(5):429-33. PubMed ID: 6752
[TBL] [Abstract][Full Text] [Related]
11. Enzyme-induced inactivation of transminases by acetylenic and vinyl analogues of 4-aminobutyrate.
John RA; Jones ED; Fowler LJ
Biochem J; 1979 Feb; 177(2):721-8. PubMed ID: 435262
[TBL] [Abstract][Full Text] [Related]
12. Antiseizure activity of gamma-acetylenic gamma-aminobutyric acid: a catalytic irreversible inhibitor of gamma-aminobutyric acid transaminase.
Schechter PJ; Tranier Y; Jung MJ; Sjoerdsma A
J Pharmacol Exp Ther; 1977 Jun; 201(3):606-12. PubMed ID: 864598
[TBL] [Abstract][Full Text] [Related]
13. Possible GABA-mediated control of dopamine-dependent behavioural effects from the nucleus accumbens of the rat.
Pycock CJ; Horton RW
Psychopharmacology (Berl); 1976 Sep; 49(2):173-8. PubMed ID: 825904
[TBL] [Abstract][Full Text] [Related]
14. On the use of enzyme inhibitors to study the synthesis and utilization of brain GABA.
Lindgren S; Andén NE
Acta Pharmacol Toxicol (Copenh); 1984 Jul; 55(1):41-9. PubMed ID: 6087618
[TBL] [Abstract][Full Text] [Related]
15. [Potential therapeutic activity of GABA-mimetic drugs in neuropsychiatry].
Bartholini G
Schweiz Arch Neurol Neurochir Psychiatr; 1979; 125(2):265-9. PubMed ID: 45343
[TBL] [Abstract][Full Text] [Related]
16. Decreased alanine aminotransferase activity in serum of man during gamma-acetylenic-GABA treatment.
Olsen R; Hørder M
Scand J Clin Lab Invest; 1980 Jun; 40(4):393-5. PubMed ID: 7414257
[TBL] [Abstract][Full Text] [Related]
17. Audiogenic seizure protection by elevated brain GABA concentration in mice: effects of gamma-acetylenic gaba and gamma-vinyl GABA, two irreversible GABA-T inhibitors.
Schechter PJ; Tranier Y; Jung MJ; Böhlen P
Eur J Pharmacol; 1977 Oct; 45(4):319-28. PubMed ID: 923642
[TBL] [Abstract][Full Text] [Related]
18. Neurochemical consequences following injection of the substance P analogue, DiMe-C7, into the rat ventral tegmental area.
Barnes JM; Barnes NM; Costall B; Cox AJ; Domeney AM; Kelly ME; Naylor RJ
Pharmacol Biochem Behav; 1990 Dec; 37(4):839-41. PubMed ID: 1709506
[TBL] [Abstract][Full Text] [Related]
19. Interactions between dopamine and GABA in the control of ambulatory activity.
Agmo A; Belzung C; Giordano M
J Neural Transm (Vienna); 1996; 103(8-9):925-34. PubMed ID: 9013386
[TBL] [Abstract][Full Text] [Related]
20. A kinetic model for the action of the enzyme activated irreversible inhibitor 4-amino-5-hexynoic acid in vivo.
Carney IT; Miller SA; Basford JM; John RA
Biochem Pharmacol; 1984 Dec; 33(23):3765-9. PubMed ID: 6508832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
